Intellipharmaceutics International Inc. (IPCI)

[cysonic]

"2Q 2017 should triple 2Q/16"

So revenue for Q2 will be around $1.8 million and the quarterly net loss should be around $1.5 million.

I think it is evident that Seroquel will bring in more than the $1.5 million per quarter, so cash flow positive in Q3 is relatively certain even if they start clinical studies of PODRAS soon.

Apart from that, the most important date still is September 25, 2017 (or an AdCom before).